Literature DB >> 14753740

Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.

Yuji Higashibata1, Takahiko Sakuma, Hirohisa Kawahata, Shinji Fujihara, Keiji Moriyama, Atsushi Okada, Takahiro Yasui, Kenjiro Kohri, Yukihiko Kitamura, Shintaro Nomura.   

Abstract

UNLABELLED: Cell-specific expression of GFP under the control of different lengths of the osteopontin promoter in transgenic mice identified the positive and negative regulatory regions for respective cell types. The results provide new insights for physiological and pathological expression of the osteopontin gene.
INTRODUCTION: Osteopontin (OPN) is a major non-collagenous bone matrix protein that is involved in normal and pathological calcification and is expressed in a tissue-specific manner. To investigate how such tissue-specific OPN gene expression is regulated in vivo, transgenic mice expressing the green fluorescent protein (GFP) reporter gene controlled by different lengths of the OPN promoter were generated.
MATERIALS AND METHODS: Cell- and developmental stage-specific osteopontin expression in transgenic mice was examined by Northern blotting, immunoblotting, fluorescence examination, and in situ hybridization and compared with those of OPN. RESULTS AND
CONCLUSIONS: The line bearing the -5505 to +14 region of the OPN promoter was shown by Northern blotting and immunoblotting to express GFP in the same cells that express endogenous OPN (osteoblasts, hypertrophic chondrocytes, renal and mammary gland epithelial cells, and granulated metrial gland [GMG] placental cells) at the same stage in development. Thus, the 5.5-kb -5505 to +14 promoter region is sufficient for proper tissue-specific OPN expression. The lines carrying shorter segments of the OPN promoter showed different expression patterns. These patterns revealed a putative cis-acting element in the -5269 to -5263 region that restricts OPN expression to hypertrophic chondrocytes and a mammary gland-specific expressing element and a GMG cell-specific enhancing element in the -5505 to -3156 region. Furthermore, the -3155 to -1576 region seems to contain positive renal epithelial cell- and GMG cell-specific expression motif(s) as well as a negative regulatory element that prevents OPN expression in fibroblasts. Moreover, the -1576 to -910 region seems to contain a positive osteoblast-specific-expressing element. Thus, the 5.5-kb OPN promoter contains multiple cis-acting elements encoding positive and negative cell-specific regulatory systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14753740     DOI: 10.1359/jbmr.2004.19.1.78

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Fine-mapping milk production quantitative trait loci on BTA6: analysis of the bovine osteopontin gene.

Authors:  Robert D Schnabel; Jong-Joo Kim; Melissa S Ashwell; Tad S Sonstegard; Curtis P Van Tassell; Erin E Connor; Jeremy F Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

2.  Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.

Authors:  Sunmi Park; Jack Zhu; Grégoire Altan-Bonnet; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 3.  Visual reporters for study of the osteoblast lineage.

Authors:  Emilie Roeder; Brya G Matthews; Ivo Kalajzic
Journal:  Bone       Date:  2016-09-08       Impact factor: 4.398

Review 4.  Biomolecular mechanism of urinary stone formation involving osteopontin.

Authors:  Kenjiro Kohri; Takahiro Yasui; Atsushi Okada; Masahito Hirose; Shuzo Hamamoto; Yasuhiro Fujii; Kazuhiro Niimi; Kazumi Taguchi
Journal:  Urol Res       Date:  2012-11-06

Review 5.  Cytokines and Abnormal Glucose and Lipid Metabolism.

Authors:  Jie Shi; Jiangao Fan; Qing Su; Zhen Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-30       Impact factor: 5.555

6.  Osteopontin: an early innate immune marker of Escherichia coli mastitis harbors genetic polymorphisms with possible links with resistance to mastitis.

Authors:  Karin Alain; Niel A Karrow; Catherine Thibault; Jessika St-Pierre; Martin Lessard; Nathalie Bissonnette
Journal:  BMC Genomics       Date:  2009-09-18       Impact factor: 3.969

7.  Down-regulation of osteopontin attenuates breast tumour progression in vivo.

Authors:  Goutam Chakraborty; Shalini Jain; Tushar V Patil; Gopal C Kundu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

8.  OPN and αvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma.

Authors:  Yi Jin; Jian-ning Chen; Zhi-ying Feng; Zhi-gang Zhang; Wen-zhe Fan; Yu Wang; Jia-ping Li
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.